資料
トリマ アクセル についての詳細
トリマ アクセル に関する文献
Deveci B, Altunay H, Veske H, et al. Enhanced donor eligibility on Trima Accel version 7.0. Vox Sang. 2017;112(suppl 1):116.
Deveci B, Altunay H, Veske H, et al. Evaluation of Trima Accel version 7.0 autoflow. Vox Sang.2017;112(suppl 1):117.
Lopert P, Rhodes J, Cancelas J, et al. A multicenter study to assess the performance of Trima Accel 7 for the collection of platelets stored in platelet additive solution. Transfusion. 2018;58(suppl 2):146A.
Lopert P, Carlin B, Irani MS, et al. Hyperconcentrated platelets collected on Trima Accel and stored in Intersol solution for 5 days meet FDA acceptance criteria for in vivo platelet recovery and survival. Transfusion.2018;58(suppl 2):146A.
Lopert P, Aga G, Rice J, et al. Apheresis platelets collected on Trima Accel and stored in Intersol platelet additive solution for 5 and 7 days are comparable for pH and morphology to plasma-stored platelets in vitro. Transfusion.2018;58(suppl 2):147A.
Argumanis ES, Ramirez MD, Gomez A, Alosilla L, Howell A, Simon-Blum L. A blood center experience—Trima Accel 7. Transfusion.2018;58(suppl 2):148A.
Lopert P, Rhodes J, Cancelas J, et al. A multicenter study to assess the performance of Trima Accel 7 for the collection of platelets stored in 100% plasma. Transfusion.2018;58(suppl 2):149A.
Rodriguez A, Forero S, Baquero D, et al. Evaluation of operational efficiencies with Trima Accel 7. Transfusion.2018;58(suppl 2):151A.
Lopert P, Rhodes J, Fender L, et al. A multicenter study to evaluate the modified postcount algorithm on the Trima Accel system. Transfusion.2018;58(suppl 2):151A.
1 Eder AF, Dy BA, DeMerse B, et al. Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions. Transfusion. 2017;57(12):2969-2976.
2 Bravo M, Shaz BH, Kamel H, et al. Detection of bacterial contamination in apheresis platelets: is apheresis technology a factor? Transfusion.2015;55(9):2113-2122.
3 Tobian AAR, King KE, Borge PD, Fuller AK, Uglik K, Ness PM. Platelet corrected count increments by apheresis platform.Transfusion. 2016;56(10):2584-2586.
一般的名称:遠心型血液成分分離装置 販売名:トリマ アクセル 医療機器承認番号:21000BZY00152000 特定保守管理医療機器
一般的名称:遠心型血液成分分離装置用血液回路 販売名:トリマ アクセル用血液回路 医療機器認証番号:22200BZX00301000
一般的名称:遠心型血液成分分離装置用血液回路 販売名:トリマ アクセル用血液回路 血漿 医療機器認証番号:225ADBZX00088000
製造販売業者:テルモBCT株式会社
〒163-1450 東京都新宿区西新宿三丁目20番2号 東京オペラシティタワー